Skip to main content
Equibles

Jeffrey Albers

Board Member

Spyre Therapeutics, Inc. (SYRE)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jeffrey Albers

Jeffrey Albers is recorded as Board Member at Spyre Therapeutics, Inc. (SYRE). Jeffrey Albers was last confirmed as Board Member at Kymera Therapeutics, Inc. (KYMR) in a filing dated April 29, 2025. Kymera Therapeutics, Inc. reported in an 8-K filed June 20, 2024 that Jeffrey Albers was appointed Audit Committee, effective June 18, 2024. Spyre Therapeutics, Inc. reported in an 8-K filed November 28, 2023 that Jeffrey Albers was appointed Member of the Board of Directors. Spyre Therapeutics, Inc. reported in an 8-K filed November 28, 2023 that Jeffrey Albers was appointed Class II director, effective November 22, 2023.

“On June 18, 2024, in connection with Dr. Horobin's resignation, and upon recommendation by the Nominating and Corporate Governance Committee, the Board appointed Jeffrey Albers, J.D., MBA, to the Audit Committee.”
Kymera Therapeutics, Inc. Form 8-K, filed June 20, 2024 · Read the filing
“The Company also announced the appointment of industry veterans Jeffrey Albers and Laurie Stelzer to its Board of Directors.”
Spyre Therapeutics, Inc. Form 8-K, filed November 28, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Spyre Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.